Bureaucracy of ethics applications

March 2004 heralded the introduction of the new Central Office for Research Ethics Committees (COREC) application form and a bad time for anyone aiming to conduct clinical research in the United Kingdom. Here I recount the experience of a clinical research group submitting the first application at t...

Full description

Saved in:
Bibliographic Details
Published inBMJ Vol. 329; no. 7460; pp. 282 - 284
Main Author Wald, David S
Format Journal Article
LanguageEnglish
Published London British Medical Journal Publishing Group 31.07.2004
British Medical Association
BMJ Publishing Group LTD
BMJ Publishing Group
BMJ Publishing Group Ltd
EditionInternational edition
Subjects
Applied ethics
Biological and medical sciences
Bureaucracy
Clinical research
Clinical trials
Committees
Data security
Dentists
Documentation - standards
Documentation - statistics & numerical data
Drug dosages
Education And Debate
Ethical Review - standards
Ethics committees
Ethics Committees, Research - organization & administration
Ethics, Medical
Funding
General aspects
Health care
Human subjects
Internet
Medical ethics
Medical research
Medical sciences
Medical technology
Pharmaceutical industry
R&D
Randomized Controlled Trials as Topic - ethics
Randomized Controlled Trials as Topic - methods
Regulatory agencies
Research & development
Research and development
Research ethics
Research facilities
Researchers
United Kingdom
United Kingdom > UK
Medicine
Ethics
Application
Public health
Biomedical and Behavioral Research
Online AccessGet full text

Cover

More Information
Summary:March 2004 heralded the introduction of the new Central Office for Research Ethics Committees (COREC) application form and a bad time for anyone aiming to conduct clinical research in the United Kingdom. Here I recount the experience of a clinical research group submitting the first application at their university hospital. We logged the time and activity required for the application process. We designed a double blind randomised, placebo controlled, factorial study in 50 volunteers to determine whether the blood pressure lowering effects of a low dose blocker and low dose angiotensin converting enzyme inhibitor are independent. We sought no external funding for the study and expected no ethical obstacles. [PUBLICATION ABSTRACT]
Bibliography:istex:4111D68206C9C3E7086321E8B2BE83678B5F6EDA
ArticleID:bmj.329.7460.282
PMID:15284157
ark:/67375/NVC-S6RG7J6N-4
href:bmj-329-282.pdf
local:bmj;329/7460/282
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Editorial by Warlow
Contributors and sources: DSW is a specialist registrar in cardiology currently engaged in clinical research.
I thank Jeff Aronson, John Dickinson, Cheryl Swann, and Karen Wald for helpful comments.
Competing interests: None declared.
ISSN:0959-8138
0959-8146
1756-1833
1468-5833
1756-1833
DOI:10.1136/bmj.329.7460.282